FDA Expands Approval of Vtama to Include Atopic Dermatitis
The nonsteroidal topical treatment is approved for patients 2 years and older
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
The monoclonal antibody treatment is for patients ages 12 years and older
Thicker Melanoma Tumor Size Tied to Higher Risk of 20-Year Melanoma-Related Death
Findings for primary tumors of 0.8 to 1.0 mm versus those <0.8 mm
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM
Dupilumab Efficacious for Atopic Dermatitis in Young Children
Findings seen for children with and without comorbidities, such as asthma, allergic rhinitis, food allergies
Celiac Disease Linked to Higher Risk for Developing Alopecia Areata
Risk 25 percent higher when comparing matched individuals with and without celiac disease
7.9 Percent of People of All Ages Uninsured in January to June 2024
No change seen in percentage of people who were uninsured from 2023 to first half of 2024; lower percentage had public coverage
Risk for Meniere Disease Higher in Patients With Atopic Dermatitis
Older age, female sex, and allergic comorbidities increase risk for developing Meniere disease
High Ultraprocessed Food Intake Linked to Active Psoriasis
Association persists after adjustment for age, BMI, alcohol intake, and comorbidities
Preferential Promotion of White Men Persisting in Academic Medicine
Black women significantly less likely to be promoted to assistant professor, full professor compared with White men
